Training future scientists in cancer research
Official title: Translational Cancer Biology (TCB) T32 Training Program
Funded at Ut Southwestern Medical Center · NIH-10933876 · Data updated 2026-11-12
This program is designed to help new researchers learn how to turn exciting lab discoveries about cancer into real treatments, so they can work together and use the latest tools to make a difference in the fight against cancer.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $432,326 |
| NIH project number | 1T32CA291654-01 |
| Project ID | NIH-10933876 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals pursuing advanced degrees in cancer biology or related fields who are interested in a career in cancer research.
✕Less likely to help
Patients who are not involved in academic or research training programs may not receive direct benefits from this research.
What this research studies
This program focuses on training pre-doctoral and post-doctoral researchers in the field of cancer biology, emphasizing the transition from laboratory discoveries to clinical applications. Participants will engage in hands-on research, learning about the latest advancements in cancer treatment and the importance of rigorous experimental design. The program also includes training in multidisciplinary teamwork, systems biology, and data analysis, preparing trainees for careers in both academic and industrial settings.
Why it matters
Potential benefit: If successful, this research could lead to the development of innovative cancer treatments and improved patient outcomes.
How similar studies have gone: Previous training programs in cancer biology have shown success in producing skilled researchers who contribute significantly to advancements in cancer treatment.
Where this research is happening
-
Ut Southwestern Medical Center
Dallas, United States Active
Researchers
- Principal investigator: Brekken, Rolf a — Ut Southwestern Medical Center
- Study coordinator: Brekken, Rolf a
Related research
Other NIH-funded projects on the same topics.
-
Developing targeted therapies for Ewing sarcoma
This study is working on new treatments for Ewing sarcoma, a cancer that mainly affects kids and teens, by finding ways to target a specific protein that helps the cancer grow, so that we can offer safer and better options for those fighting this disease.
-
Neural roots of how autistic adults understand word meaning
A study to understand how adults with autism process word meanings in the brain, aiming to improve language support.
-
A new approach to healing NF1-related tibia fractures in children
This grant aims to understand why some NF1-related leg fractures in kids don’t heal well and to develop better treatments to help them recover without complications.
-
Multi-center study on how ventilation during CPR relates to cardiac arrest outcomes
A large, real-world study will look at how ventilation during CPR affects survival after out-of-hospital cardiac arrest in adults.
-
National Spina Bifida Patient Registry across the U.S.
A national registry collects health information from people with spina bifida to help doctors and families get better, more consistent care.
-
MONA-LISA: Understanding Why Autoimmune Signals Turn into Lupus Over Time
A study using data and samples from people with early autoimmune signs to understand why some develop full-blown lupus and others do not.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.